SCHEMBL13854151

SCHEMBL13854151

CCOP(=O)(CCCCNC(=O)OCc1ccccc1)OC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.54
▸ TGM2 P21980 1/20 0.52
▸ KEAP1 Q14145 3/20 0.50
▸ NFE2L2 Q16236 3/20 0.50
▸ LMNA P02545 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ MAPT P10636 1/20 0.47
▸ CA1 P00915 1/20 0.46
▸ CA2 P00918 1/20 0.46
▸ HDAC3 O15379 1/20 0.46
▸ HDAC4 P56524 1/20 0.46
▸ HDAC1 Q13547 1/20 0.46
▸ HDAC7 Q8WUI4 1/20 0.46
▸ HDAC2 Q92769 1/20 0.46
▸ HDAC10 Q969S8 1/20 0.46
▸ HDAC11 Q96DB2 1/20 0.46
▸ HDAC8 Q9BY41 1/20 0.46
▸ HDAC6 Q9UBN7 1/20 0.46
▸ HDAC9 Q9UKV0 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13853971 0.94 HTT (0.58) HTTTGM2KEAP1NFE2L2LMNA
SCHEMBL1439677 0.85 LMNA (0.57) HTTTGM2KEAP1NFE2L2LMNA
SCHEMBL9202853 0.85 HTT (0.55) HTTTGM2KEAP1NFE2L2LMNA
SCHEMBL13725441 0.83 HTT (0.59) HTTTGM2KEAP1NFE2L2LMNA
SCHEMBL9204222 0.82 LMNA (0.53) HTTTGM2KEAP1NFE2L2LMNA
SCHEMBL7282990 0.81 HSD17B10 (0.56) HTTLMNASMN1; SMN2L3MBTL1MAPT
SCHEMBL24486765 0.80 HTT (0.65) HTTTGM2KEAP1NFE2L2LMNA
SCHEMBL18254066 0.79 HTT (0.81) HTTTGM2KEAP1NFE2L2LMNA
SCHEMBL1442202 0.79 LMNA (0.56) HTTTGM2KEAP1NFE2L2LMNA
SCHEMBL1440479 0.79 LMNA (0.56) HTTTGM2KEAP1NFE2L2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090123507-A1 Metal Oxide Nanoparticles Coated With Specific N-Acylaminomethylene Phosphonates CIBA SPECIALTY CHEMICALS CORP. 2009-05-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090123507-A1 Metal Oxide Nanoparticles Coated With Specific N-Acylaminomethylene Phosphonates PHOSPHO1, ACP1, PNN HTT 2508/4885TGM2 2740/4885KEAP1 3649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback